Ekaterina Kldiashvili, Irakli Khuntsaria, Elene Kekelia, Ana Mamiseishvili, Mariam Abuladze
Petre Shotadze Tbilisi Medical Academy Tbilisi Georgia.
Health Sci Rep. 2025 Apr 23;8(4):e70768. doi: 10.1002/hsr2.70768. eCollection 2025 Apr.
Cervical cancer is a major health issue globally, particularly in developing countries where it remains a leading cause of cancer-related deaths among women. In Georgia, it ranks as the fifth most frequent cancer among women overall and the third among women aged 15-44 years. Approximately 1.60 million women aged 15 years and older in Georgia are at risk of developing cervical cancer. Annually, about 327 women are diagnosed, and 204 die from the disease. Screening for cervical cancer is crucial for reducing incidence and mortality rates. While the conventional Pap smear has been the primary screening method, its limitations in sensitivity and sample adequacy have led to the development of liquid-based cytology (LBC).
This study analyzed 1000 cervical cytology samples from women aged 18-65 years in Georgia, who were gynecologically asymptomatic and not vaccinated for HPV. The median age was 37 years. Informed consent was obtained for all participants. Samples were collected using ThinPrep reagents (Hologic) and processed within 2 h. Smears were prepared using the ThinPrep 2000 Processor, fixed in absolute alcohol for 30 min, and stained according to the Papanicolaou protocol. The Bethesda 2001 System terminology was used for reporting. Smears were evaluated by light microscopy and archived per Georgian medical data requirements.
The study found significant differences between the two screening methods. LBC showed a higher rate of satisfactory smears and better detection rates for negative for intraepithelial lesion or malignancy-NILM (89.4% vs. 80.3% for conventional Pap smear). Unsatisfactory smears were significantly lower with LBC (1.33% vs. 7.33%). Detection rates for atypical squamous cells of undetermined significance (ASCUS), atypical squamous cells, cannot exclude high grade squamous intraepithelial lesion (ASC-H), low grade squamous intraepithelial lesion (LSIL), and high grade squamous intraepithelial lesion (HSIL) were also improved with LBC, indicating higher diagnostic accuracy.
LBC outperforms the conventional Pap smear in cervical cancer screening by providing higher sample adequacy, better detection rates, and greater diagnostic accuracy. Implementing LBC more widely in Georgia could enhance early detection rates and reduce cervical cancer incidence and mortality, particularly in high-risk populations. These findings support the adoption of LBC as a superior screening method in clinical practice.
宫颈癌是全球主要的健康问题,在发展中国家尤为突出,仍是女性癌症相关死亡的主要原因。在格鲁吉亚,宫颈癌在女性总体癌症中排名第五,在15 - 44岁女性中排名第三。格鲁吉亚约有160万15岁及以上的女性有患宫颈癌的风险。每年约有327名女性被诊断出患有宫颈癌,204人死于该疾病。宫颈癌筛查对于降低发病率和死亡率至关重要。虽然传统巴氏涂片一直是主要的筛查方法,但其在敏感性和样本充足性方面的局限性促使了液基细胞学(LBC)的发展。
本研究分析了格鲁吉亚1000例18 - 65岁女性的宫颈细胞学样本,这些女性妇科无症状且未接种HPV疫苗。中位年龄为37岁。所有参与者均获得了知情同意。使用ThinPrep试剂(Hologic)收集样本,并在2小时内进行处理。使用ThinPrep 2000处理器制备涂片,用无水乙醇固定30分钟,并按照巴氏染色法进行染色。采用贝塞斯达2001系统术语进行报告。通过光学显微镜对涂片进行评估,并根据格鲁吉亚医疗数据要求进行存档。
该研究发现两种筛查方法之间存在显著差异。LBC显示出满意涂片的比例更高,上皮内病变或恶性病变阴性(NILM)的检测率更高(传统巴氏涂片为80.3%,LBC为89.4%)。LBC不满意涂片的比例显著更低(1.33%对7.33%)。LBC对意义不明确的非典型鳞状细胞(ASCUS)、非典型鳞状细胞、不能排除高级别鳞状上皮内病变(ASC-H)、低级别鳞状上皮内病变(LSIL)和高级别鳞状上皮内病变(HSIL)的检测率也有所提高,表明诊断准确性更高。
在宫颈癌筛查中,LBC通过提供更高的样本充足性、更好的检测率和更高的诊断准确性,优于传统巴氏涂片。在格鲁吉亚更广泛地应用LBC可以提高早期检测率,降低宫颈癌的发病率和死亡率,特别是在高危人群中。这些发现支持将LBC作为临床实践中一种更优的筛查方法。